HOAG DVT PREVENTION PROGRAM

NO ONE HANDLES MORE DVT PATIENTS THAN US

THE PROBLEM

Financial impact

Financial impact rising costs for patient readmittance for DVT or associated wound care from device usage is growing.

 

Patient safety:

Patient safety adverse drug events, bleeding risks of anti-coagulants can be mitigated by mechanical prophylaxis as stated by the Joint Commission.

 

Patient Care:

Patient are at the highest risk 5-10 days post surgery for DVT. Patient compliance at home is the largest gap in all healthcare. Providing a solution for in home use is the future of post surgery care.

usa-2

More Americans die from DVT than breast cancer, AIDS and traffic fatalities combined.

Patients are at the highest risk 5-10 days post surgery

VTE is a leading cause of preventable hospital deaths in United States

UNTETHERED DVT SOLUTION

We are the #1 Standard of Care for DVT Prevention, providing hospitals the most efficient DVT program nationwide by decreasing your workload, increasing patient outcomes and providing the most compliant program for your hospital.

Does your current dvt program do the following?

FINANCIAL IMPACT WITH CIRCUL8

FINANCIAL ANALYSIS SUPPORTS THE CIRCUL8 DEVICE
  • COST DECREASE – Earlier discharge time. read more
  • COST DECREASE – Decreased readmission. read more
  • COST DECREASE – Tubeless device. read more
  • COST DECREASE – Infection control. read more
  • COST DECREASE – Single patient use. read more
  • COST DECREASE – Speed up lag time. read more
  • COST DECREASE – No hidden costs and fees. read more

Hospital need-
Reduce spending and improve quality across the bundled episode. Unlike earlier bundling efforts, CJR includes all related spending for 90 days post-discharge. A readmitted DVT can cost up to $16k and a PE up to $48k.
Bonuses –
To earn bonuses during the annual reconciliation process, hospitals need to reduce spending on post discharge care and readmissions.
Increase HCACP scores.
As our healthcare system continues its move toward an outcomes/value-based environment, patient feedback regarding their personal experience will undoubtedly become increasingly important. A critical indicator of patient satisfaction is HCAHPS, or Hospital Consumer Assessment of Healthcare Providers and Systems.

DECREASING COSTS

PATIENT SAFETY - CIRCUL8

IMPROVE OUTCOMES, REDUCE COST OF EPISODE, SIMPLIFY LOGISTICS AND INCREASE
PATIENT SATISFACTION BY PROVIDING A TUBELSS PORTABLE DVT DEVICE.

IMPROVE PATIENT OUTCOMES

  • Reduce risk of DVT with at home sequential compression device
  • Lower risk/side effects compared to anticoagulants or pharmacologic options
  • Decrease risk of falls in and out of the hospital by eliminating tubes
  • Earlier discharges
  • Reduce risk of wounds by eliminating tubing

IMPROVE PATIENT SATISFACTION

  • Provide comfort and relief through compression
  • Improve convenience with tubeless and battery operated design
  • Improve patient scores and feedback with cutting edge technology

PATIENT SAFETY

FALL RISK AND WOUND MANAGEMENT
  • Cost to treat a wound = $20,900 – $151,700
  • Cost to treat a fall = $30,000
  • Cost to treat a bleeding complication = $140,701
  • Liability Risks = $$ Varies

INDUSTRY LEADING PATIENT CARE

CUSTOM PATIENT EDUCATION PORTAL (PEP)
PROVIDED TO EACH PATIENT

Custom Patient Portal branded to Hoag for increased
patient compliance and increased outcomes.

  • Product Instructions
  • Product Videos
  • Patient Tutorials
  • Frequently Asked Questions
  • Automated Patient Follow Up System
  • Pre-Charged Units
  • Direct Ship Inventory Management

Here is your example portal: Hoag.precisionpatient.com

TRUSTED PARTNERS

JOIN MORE THAN 300 HEALTHCARE CENTERS AND PROVIDERS
WHO TRUST PRECISION MEDICAL PRODUCTS
basm
surgcenter

CIRCUL8

CIRCUL8 IS A REVOLUTIONARY DEVICE THAT IS DESIGNED TO PREVENT DVT

PRODUCT DESCRIPTION & CLINICAL IMPACT

The Circul8 is intended to be an easy to use portable system, prescribed by a physician, for use in the home or clinical setting to help prevent the onset of DVT in patients by stimulating blood flow in the extremities (stimulating muscle contractions). This device can be used to:

  • Aid in the prevention of DVT
  • Enhance blood circulation
  • Diminish post-operative pain and swelling
  • Reducing wound healing time
  • Aid in the treatment and healing of: stasis dermatitis, venous stasis ulcers, arterial and diabetic leg ulcers, chronic venous insufficiency and reduction of enema in the lower limbs.
  • The unit can also be uses as an aid in the prophylaxis for DVT by persons expecting to be stationary for long periods of time.

  • No tubes
  • Battery operated and rechargable
  • Over 8 hours of battery life
  • Bluetooth app for patient compliance

PATIENT SAFETY - CLINICAL




CONCLUSION

CIRCUL8 SHOULD BE CONSIDERED AS THE GOLD STANDARD FOR HOAG HOSPITAL

FINANCIAL IMPACT

Circul8 will speed up discharge, mitigate the risk for a readmission DVT, eliminate large service contracts, reduce labor costs, and decrease the fall risk at the facility.

 

PATIENT SAFETY

Circul8 will improve clinical outcomes by decreasing blood clots and bleeding associated with pharmacalogic options.

 

PATIENT CARE

Improve patient scores and feedback with cutting edge technology and one of a kind patient education.

 

CLINICAL SUPPORT

Sequential compression devices have been studied for over 26 years. Recent studies show compresssion therapy with aspirin after a total joint resulted in a blood clot rate of 0%. Board guidelines also recognize the use of this device at the home setting.

AMY LINDHORST

916.802.5756
amy@pmpmed.com

WORK WITH THE LEADING DVT SOLUTION COMPANY

PLEASE REACH OUT TO ME WITH ANY QUESTIONS YOU HAVE